Status
Conditions
About
Lower urinary tract symptoms in transmasculine patients undergoing metoidioplasty and their acceptability of pelvic floor muscle training assessed by a Pelvic, Obstetric and Gynaecological Physiotherapist.
Study Design
Prospective observational pilot study
Study Participants
Transmasculine patients undergoing metoidioplasty
Planned Sample Size
50
Planned Study Period
2025/26
Objectives
Understand the acceptability of first-line pelvic floor muscle training (PFMT) treatment in transmasculine patients undergoing metoidioplasty
Background incidence of lower urinary tract symptoms (LUTS) in transmasculine patients undergoing surgery
Endpoints
Acceptability of PFMT questionnaire
International Prostate Symptom Score (I-PSS) and International Consultation on Incontinence Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF) questionnaires and uroflowmetry
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Have capacity to consent.
Diagnosis of gender dysphoria and have lived in a gender role that is congruent to their gender identity for minimum of 12 months.
Transmasculine patients referred to CCGS for masculinising lower genital reconstructive surgery having received two signatures confirming suitability for reconstructive surgery.
Undergoing metoidioplasty/phalloplasty.
Age >17 years old.
On systemic testosterone therapy for more than 12 months.
Exclusion criteria
Not undergoing metoidioplasty/phalloplasty.
Loading...
Central trial contact
Rufus Cartwright, MA MD(res) PhD MRCOG
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal